Crossmark

Anti-T lymphocyte globulin plus posttransplant cyclophosphamide 25 mg/kg versus posttransplant cyclophosphamide 50 mg/kg in patients with acute leukemias

Crossref DOI link: https://doi.org/10.1038/s41409-025-02564-8

Published Online: 2025-04-13

Published Print: 2025-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Karakus, Abdullah https://orcid.org/0000-0003-2090-4392
Toptas, Tayfur

Dal, Mehmet Sinan https://orcid.org/0000-0002-5994-2735
Durdu, Ali

Hatipoglu, Ugur https://orcid.org/0000-0003-1852-8957
Kayer, Merve Apaydin

Hindilerden, Ipek Yonal https://orcid.org/0000-0003-1353-2367
Tiryaki, Tarik Onur https://orcid.org/0000-0002-0096-5684
Iskender, Dicle

Ulu, Bahar Uncu https://orcid.org/0000-0002-6230-9519
Yigenoglu, Tugce Nur https://orcid.org/0000-0001-9962-8882
Erkurt, Mehmet Ali

Ulas, Turgay https://orcid.org/0000-0001-9332-663X
Altuntas, Fevzi https://orcid.org/0000-0001-6872-3780
License Information

Text and Data Mining valid from 2025-04-13

Version of Record valid from 2025-04-13
More Information

Article History

Received: 3 December 2024

Revised: 15 February 2025

Accepted: 21 March 2025

First Online: 13 April 2025

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below